CTI acquires BGO firm

Article

Cyclotron developer CTI of Knoxville, TN, last month acquired Advanced Crystal Technology from Nihon Kessho Koogaku, a subsidiary of Mitsui Mining and Smelting. The deal helps CTI expand its PET imaging product portfolio, and gives it increased access to

Cyclotron developer CTI of Knoxville, TN, last month acquired Advanced Crystal Technology from Nihon Kessho Koogaku, a subsidiary of Mitsui Mining and Smelting. The deal helps CTI expand its PET imaging product portfolio, and gives it increased access to bismuth germanate (BGO), a key detector component in PET devices. ACT is the primary supplier of BGO to CTI PET Systems, the joint venture between CTI and Siemens Nuclear Medicine Group of Hoffman Estates, IL.

ACT is based in Rockford, TN, and was established in 1988. CTI will keep existing ACT employees at the Rockford site, but will move the company’s marketing and R&D operations to CTI’s corporate offices in Knoxville.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.